ADH1B and prostate carcinoma: Combining the effects of the ADH1B SNP on alcohol intake with the upper confidence intervals from our results implies that a 17% reduction in alcohol consumption is unlikely to reduce prostate cancer risk by >3% and prostate cancer mortality by >5%.